Clovis Oncology to Present at the Stifel 2017 Healthcare Conference
09 November 2017 - 10:40AM
Business Wire
Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that its
Chief Executive Officer and President, Patrick J. Mahaffy, will
present at the Stifel 2017 Healthcare Conference on Wednesday,
November 15, 2017 at 9:30 AM Eastern Time. The conference will be
held at the Lotte New York Palace Hotel in New York City.
A live webcast of the presentation can be accessed through the
investor relations section of the Company’s website at
www.clovisoncology.com. Following the live presentation, a replay
of the webcast will be available on the Company’s website for 30
days.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on
acquiring, developing and commercializing innovative anti-cancer
agents in the U.S., Europe and additional international markets.
Clovis Oncology targets development programs at specific subsets of
cancer populations, and simultaneously develops, with partners,
diagnostic tools that direct a compound in development to the
population that is most likely to benefit from its use. Clovis
Oncology is headquartered in Boulder, Colorado, and has additional
offices in San Francisco, California and Cambridge, UK. Please
visit www.clovisoncology.com for more information.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171108006692/en/
Clovis Oncology, Inc.Anna Sussman,
303-625-5022asussman@clovisoncology.comorBreanna Burkart,
303-625-5023bburkart@clovisoncology.com
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From Sep 2023 to Sep 2024
Real-Time news about Clovis Oncology Inc (NASDAQ): 0 recent articles
More Clovis Oncology, Inc. (MM) News Articles